Jessica Kirshner

Company: Regeneron Pharmaceuticals Inc

Job title: Executive Director

Seminars:

Targeting Alternative T cell Effector Pathways to Enhance the Activity of CD3-Engaging Bispecific Antibodies 2:00 pm

Regeneron’s approach to improving cytotoxic T cell activity by adding co-stimulatory targeted biologics Examples from hematological and solid tumors Exploring what are the optimal co-stimulatory agents to activate T cells in combination with CD3 bispecifics?Read more

day: Conference Day 2